These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8395460)

  • 1. Fatty-acid metabolism and the pathogenesis of hepatocellular carcinoma: review and hypothesis.
    Ockner RK; Kaikaus RM; Bass NM
    Hepatology; 1993 Sep; 18(3):669-76. PubMed ID: 8395460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of metabolism in the activation of dehydroepiandrosterone as a peroxisome proliferator.
    Waxman DJ
    J Endocrinol; 1996 Sep; 150 Suppl():S129-47. PubMed ID: 8943797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proliferation of peroxisomes and the hepatocarcinogenic process].
    Palut D
    Rocz Panstw Zakl Hig; 1997; 48(1):1-11. PubMed ID: 9273657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of retinoic acid receptor in steatohepatitis-related tumor formation.
    Shiota G
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S101-7. PubMed ID: 17567456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Peroxisomal beta-oxidation].
    Mannaerts GP; Van Veldhoven PP
    Verh K Acad Geneeskd Belg; 1993; 55(1):45-78. PubMed ID: 8480447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
    Nakamuta M; Kohjima M; Morizono S; Kotoh K; Yoshimoto T; Miyagi I; Enjoji M
    Int J Mol Med; 2005 Oct; 16(4):631-5. PubMed ID: 16142397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights in peroxisomal beta-oxidation. Implications for human peroxisomal disorders.
    Van Veldhoven PP
    Verh K Acad Geneeskd Belg; 1998; 60(3):195-214. PubMed ID: 9803880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation.
    Reddy JK; Rao MS
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G852-8. PubMed ID: 16603729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Less extrahepatic induction of fatty acid beta-oxidation enzymes by PPAR alpha.
    Cook WS; Yeldandi AV; Rao MS; Hashimoto T; Reddy JK
    Biochem Biophys Res Commun; 2000 Nov; 278(1):250-7. PubMed ID: 11071880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sequential cellular and molecular changes during hepatocarcinogenesis].
    Bannasch P
    Verh Dtsch Ges Pathol; 1995; 79():72-83. PubMed ID: 8600697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
    Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
    Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consequences of mitochondrial injury induced by pharmaceutical fatty acid oxidation inhibitors is characterized in human and rat liver slices.
    Vickers AE; Bentley P; Fisher RL
    Toxicol In Vitro; 2006 Oct; 20(7):1173-82. PubMed ID: 16545538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisomal branched chain fatty acid beta-oxidation pathway is upregulated in prostate cancer.
    Zha S; Ferdinandusse S; Hicks JL; Denis S; Dunn TA; Wanders RJ; Luo J; De Marzo AM; Isaacs WB
    Prostate; 2005 Jun; 63(4):316-23. PubMed ID: 15599942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic syndrome and the hepatic fatty acid drainage hypothesis.
    Berge RK; Tronstad KJ; Berge K; Rost TH; Wergedahl H; Gudbrandsen OA; Skorve J
    Biochimie; 2005 Jan; 87(1):15-20. PubMed ID: 15733731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary sesamin and docosahexaenoic and eicosapentaenoic acids synergistically increase the gene expression of enzymes involved in hepatic peroxisomal fatty acid oxidation in rats.
    Arachchige PG; Takahashi Y; Ide T
    Metabolism; 2006 Mar; 55(3):381-90. PubMed ID: 16483883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice.
    Tanaka N; Moriya K; Kiyosawa K; Koike K; Gonzalez FJ; Aoyama T
    J Clin Invest; 2008 Feb; 118(2):683-94. PubMed ID: 18188449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does increased fatty acid oxidation enhance development of liver cirrhosis and progression to hepatocellular carcinoma in patients with glycogen storage disease type-III?
    Herrema H; Smit GP; Reijngoud DJ; Kuipers F
    J Hepatol; 2007 Aug; 47(2):298-300; author reply 300-1. PubMed ID: 17570555
    [No Abstract]   [Full Text] [Related]  

  • 18. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
    Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
    Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling in livers of mice after acute inhibition of beta-oxidation.
    van der Leij FR; Bloks VW; Grefhorst A; Hoekstra J; Gerding A; Kooi K; Gerbens F; te Meerman G; Kuipers F
    Genomics; 2007 Dec; 90(6):680-9. PubMed ID: 17933490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation of mitochondrial fatty acid oxidation and hepatic gene expression by catecholamine.
    Barke RA; Brady PS; Brady LJ
    J Surg Res; 1993 Feb; 54(2):95-101. PubMed ID: 8479178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.